Rezum therapy, a feasible and safe treatment for the larger prostate. (May 2021)

• Record Type: Journal Article
• Authors: Rowaiee, Rashed; Akhras, Aya; Janahi, Farhad Kheradmand
• Is Part Of: International journal of surgery case reports. Volume 82(2021)
• Publication Date: 2021-05
• Subjects: Rezum -- Benign prostatic hyperplasia -- Lower urinary tract symptoms -- Minimally invasive treatment -- Case report; Surgery -- Periodicals; Surgical Procedures, Operative -- Periodicals; Surgery; Electronic journals; Periodicals; 617.005
• DOI: 10.1016/j.ijscr.2021.105871
• Languages: English
• ISSNs: 2210-2612

Abstract

Highlights: Rezum is a novel approach to treating BPH symptoms in patients with prostates <80 cc while maintaining sexual function. Based on our case, Rezum may also be considered as a MIT for BPH in patients with larger prostates, with a good safety profile. Abstract: Benign prostatic hyperplasia (BPH) is the leading cause of Lower Urinary Tract Symptoms (LUTS) in men worldwide. Urinary frequency, nocturia and incomplete emptying are common symptoms experienced by men with BPH, which significantly reduce their quality of life. Treatment for this dysfunction includes surgical and non-surgical modalities such as watchful waiting, lifestyle modification and medication. Historically, Transurethral Resection of the Prostate (TURP) had been considered the gold standard mainstay of treatment; however, in recent years, minimally invasive techniques which offer similar outcomes, fewer complications and cost-effectiveness have gained popularity. Rezum, is a relatively new minimally invasive modality used to treat BPH which has been recommended for prostate volumes of ≤80 cc. Herein, we present a successful case of managing BPH in a middle-aged patient with a prostate volume of 186 cc.